By Matt Fair ( January 10, 2018, 7:30 PM EST) -- It may seem Johnson & Johnson suffered a major blow after a Pennsylvania appeals court recently put the prospect of punitive damages back on the table in thousands of Risperdal breast-growth cases in Philadelphia, but attorneys say convincing trial judges to greenlight any such awards will be no easy task....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.